These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9422538)

  • 41. Diagnostic utility of LMO2 immunohistochemistry in distinguishing T-lymphoblastic leukemia/lymphoma from thymoma.
    Bansal D; Pasricha S; Gupta G; Sharma A; Durga G; Kamboj M; Mehta A
    Indian J Pathol Microbiol; 2024; 67(1):141-144. PubMed ID: 38358204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD21 antigen in T-lineage neoplastic lymphoid cells: characteristic expression at thymic stage.
    Tatsumi E; Yoneda N; Kawano S; Yamaguchi N
    Am J Hematol; 1994 Feb; 45(2):150-5. PubMed ID: 7511331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma.
    Nagel S; Leich E; Quentmeier H; Meyer C; Kaufmann M; Drexler HG; Zettl A; Rosenwald A; MacLeod RA
    Leukemia; 2008 Feb; 22(2):387-92. PubMed ID: 17989712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.
    Corcoran MM; Mould SJ; Orchard JA; Ibbotson RE; Chapman RM; Boright AP; Platt C; Tsui LC; Scherer SW; Oscier DG
    Oncogene; 1999 Nov; 18(46):6271-7. PubMed ID: 10597225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cysteine protease CPP32, but not Ich1-L, is expressed in germinal center B cells and their neoplastic counterparts.
    Xerri L; Devilard E; Ayello C; Brousset P; Reed JC; Emile JF; Hassoun J; Parmentier S; Birg F
    Hum Pathol; 1997 Aug; 28(8):912-21. PubMed ID: 9269827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of WT1 gene product in non-Hodgkin lymphomas.
    Drakos E; Rassidakis GZ; Tsioli P; Lai R; Jones D; Medeiros LJ
    Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):132-7. PubMed ID: 15894924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of oncoprotein 18 in human leukemias and lymphomas.
    Roos G; Brattsand G; Landberg G; Marklund U; Gullberg M
    Leukemia; 1993 Oct; 7(10):1538-46. PubMed ID: 8412315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CDK1 and cyclin A expression is linked to cell proliferation and associated with prognosis in non-Hodgkin's lymphomas.
    Wolowiec D; Berger F; Ffrench P; Bryon PA; Ffrench M
    Leuk Lymphoma; 1999 Sep; 35(1-2):147-57. PubMed ID: 10512172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flow cytometry in the diagnosis of mediastinal tumors with emphasis on differentiating thymocytes from precursor T-lymphoblastic lymphoma/leukemia.
    Gorczyca W; Tugulea S; Liu Z; Li X; Wong JY; Weisberger J
    Leuk Lymphoma; 2004 Mar; 45(3):529-38. PubMed ID: 15160915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of classical protein kinase C subspecies in non-neoplastic lymphocytes and non-Hodgkin's lymphomas: an immunohistochemical study.
    Hojo H; Morimura Y; Abe M; Wakasa H
    Pathol Int; 1996 Feb; 46(2):148-54. PubMed ID: 10846563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CDK6: an attractive therapeutic target for T-ALL/LBL.
    Li W; Hu JK; Hu MG
    Expert Opin Ther Targets; 2023; 27(11):1087-1096. PubMed ID: 37975616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis.
    Gary JM; Simmons JK; Xu J; Zhang S; Peat TJ; Watson N; Gamache BJ; Zhang K; Kovalchuk AL; Michalowski AM; Chen JQ; Thaiwong T; Kiupel M; Gaikwad S; Etienne M; Simpson RM; Dubois W; Testa JR; Mock BA
    Mol Cancer Ther; 2020 Oct; 19(10):2221-2232. PubMed ID: 32747423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia.
    Jena N; Sheng J; Hu JK; Li W; Zhou W; Lee G; Tsichlis N; Pathak A; Brown N; Deshpande A; Luo C; Hu GF; Hinds PW; Van Etten RA; Hu MG
    Leukemia; 2016 May; 30(5):1033-43. PubMed ID: 26707936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of p53 in pediatric lymphomas from Mexico.
    Venkatesh H; Mezacoria C; Lopezcorella E; Ridaurasanz C; Oconor G; Luna R; Bhatia K; Magrath I
    Int J Oncol; 1997 Sep; 11(3):477-80. PubMed ID: 21528235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis.
    Hu MG; Deshpande A; Enos M; Mao D; Hinds EA; Hu GF; Chang R; Guo Z; Dose M; Mao C; Tsichlis PN; Gounari F; Hinds PW
    Cancer Res; 2009 Feb; 69(3):810-8. PubMed ID: 19155308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of the promyelocytic leukemia zinc-finger in T-lymphoblastic lymphoma and leukemia has strong implications for their cellular origin and greater association with initial bone marrow involvement.
    Jeon YK; Go H; Nam SJ; Keam B; Kim TM; Jung KC; Kang HJ; Lee DS; Huh JR; Park SH
    Mod Pathol; 2012 Sep; 25(9):1236-45. PubMed ID: 22555178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders.
    Chen D; Law ME; Theis JD; Gamez JD; Caron LB; Vrana JA; Dogan A
    Am J Surg Pathol; 2009 May; 33(5):720-9. PubMed ID: 19145199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expression of CDK6 and FOXM1 in peripheral T-cell lymphoma and their significance].
    Feng HN; Shao XX; Bu P; Zhang F; Wang YJ; Xi YF; Guo WN
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):594-600. PubMed ID: 32486537
    [No Abstract]   [Full Text] [Related]  

  • 59. Bcl-2 maturation pattern in T-cells distinguishes thymic neoplasm/hyperplasia, T-lymphoblastic lymphoma, and reactive lymph nodes.
    Ward N; Baqai J; Zehnpfennig A; Fine N; Huang J; Smith MD
    Cytometry B Clin Cytom; 2018 May; 94(3):444-450. PubMed ID: 28718205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets.
    Lin YW; Aplan PD
    Leukemia; 2007 Jun; 21(6):1276-84. PubMed ID: 17429429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.